Interactions between Bordetella pertussis and the complement inhibitor factor H

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 697-705

  Amdahl, Hanne ^a   Jarva, Hanna ^a,b   Haanperä, Marjo ^c   Mertsola, Jussi ^d   He, Qiushui ^c   Jokiranta, T Sakari ^a   Meri, Seppo ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

B. parapertussis; Bacteria; Bordetella; Complement; Evasion; Factor H; Pertussis; Vaccine; Whooping cough

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H;

ADSORPTION; ARTICLE; BINDING ASSAY; BORDETELLA AVIUM; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CARBOXY TERMINAL SEQUENCE; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

BINDING SITES; BLOOD PROTEINS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; COMPLEMENT FACTOR H; COMPLEMENT INACTIVATING AGENTS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MICROBIAL VIABILITY; PROTEIN BINDING;

AVES; BORDETELLA; BORDETELLA AVIUM; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS;

EID: 78650590511     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.11.015     Document Type: Article

References (60)

1. Alsenz J., Schulz T.F., Lambris J.D., Sim R.B., Dierich M.P. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 1985, 3:841-850.
2. Barnes M.G., Weiss A.A. Growth phase influences complement resistance of Bordetella pertussis. Infect. Immun. 2002, 1:403-406.
3. Berggard K., Johnsson E., Mooi F.R., Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect. Immun. 1997, 9:3638-3643.
4. Berner R., Krause M.F., Gordjani N., Zipfel P.F., Boehm N., Krueger M., Brandis M., Zimmerhackl L.B. Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis. Pediatr. Nephrol. 2002, 3:190-192.
5. Black W.J., Falkow S. Construction and characterization of Bordetella pertussis toxin mutants. Infect. Immun. 1987, 10:2465-2470.
6. Caro V., Bouchez V., Guiso N. Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?. J. Clin. Microbiol. 2008, 6:2125-2128.
7. Chaturvedi S., Licht C., Langlois V. Hemolytic uremic syndrome caused by Bordetella pertussis infection. Pediatr. Nephrol. 2010, 7:1361-1364.
8. Cookson B.T., Vandamme P., Carlson L.C., Larson A.M., Sheffield J.V., Kersters K., Spach D.H. Bacteremia caused by a novel Bordetella species, "B. hinzii" J. Clin. Microbiol. 1994, 10:2569-2571.
9. Dahlback B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 1983, 3:847-856.
10. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 5720:421-424.
11. Elder K.D., Harvill E.T. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect. Immun. 2004, 10:5919-5924.
12. Elderling G., Kendrick P.L. Incidence of B. parapertussis in the Grand Rapids area as indicated by 16 years' experience with diagnostic cultures. Am. J. Public Health Nations Health 1952, 1:27-31.
13. Fennelly N.K., Sisti F., Higgins S.C., Ross P.J., van der Heide H., Mooi F.R., Boyd A., Mills K.H.G. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect. Immun. 2008, 76:1257-1266.
14. Fernandez R.C., Weiss A.A. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 1998, 1:57-63.
15. Finn T.M., Stevens L.A. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 1995, 4:625-634.
16. Friberg N., Carlson P., Kentala E., Mattila P.S., Kuusela P., Meri S., Jarva H. Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum. J. Immunol. 2008, 12:8624-8632.
17. Goodnow R.A. Biology of Bordetella bronchiseptica. Microbiol. Rev. 1980, 4:722-738.
18. Gross R., Guzman C.A., Sebaihia M., Martins Dos Santos V.A., Pieper D.H., Koebnik R., Lechner M., Bartels D., Buhrmester J., Choudhuri J.V., Ebensen T., Gaigalat L., Herrmann S., Khachane A.N., Larisch C., Link S., Linke B., Meyer F., Mormann S., Nakunst D., Rueckert C., Schneiker-Bekel S., Schulze K., Vorhoelter F.J., Yevsa T., Engle J.T., Goldman W.E., Puehler A., Goebel U.B., Goesmann A., Bloecker H., Kaiser O., Martinez-Arias R. The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae. BMC Genomics 2008, 1:449.
19. Haapasalo K., Jarva H., Siljander T., Tewodros W., Vuopio-Varkila J., Jokiranta T.S. Complement Factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Mol. Microbiol. 2008, 70:583-594.
20. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 2005, 20:7227-7232.
21. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 5720:419-421.
22. Harrington A.T., Castellanos J.A., Ziedalski T.M., Clarridge J.E., Cookson B.T. Isolation of Bordetella avium a novel Bordetella strain from patients with respiratory disease. Emerg. Infect. Dis. 2009, 1:72-74.
23. He Q., Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008, 3:329-339.
24. Heikkinen E., Kallonen T., Saarinen L., Sara R., King A.J., Mooi F.R., Soini J.T., Mertsola J., He Q. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS ONE 2007, 9:e904.
25. Hellwage J., Meri T., Heikkila T., Alitalo A., Panelius J., Lahdenne P., Seppala I.J., Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 2001, 11:8427-8435.
26. Hinz K.H., Glunder G., Luders H. Acute respiratory disease in turkey poults caused by Bordetella bronchiseptica-like bacteria. Vet. Rec. 1978, 12:262-263.
27. Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. 1988, 85:1657-1661.
28. Jarva H., Jokiranta T.S., Wurzner R., Meri S. Complement resistance mechanisms of streptococci. Mol. Immunol. 2003, 2-4:95-107.
29. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 2000, 36:27657-27662.
30. Jokiranta T.S., Jaakola V.P., Lehtinen M.J., Parepalo M., Meri S., Goldman A. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 2006, 8:1784-1794.
31. Jozsi M., Richter H., Loschmann I., Skerka C., Buck F., Beisiegel U., Erdei A., Zipfel P.F. FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur. J. Hum. Genet. 2005, 3:321-329.
32. Kasuga T., Nakase Y., Ukishima K., Takatsu K. Studies on Haemophilus pertussis. V. Relation between the phase of bacilli and the progress of the whooping-cough. Kitasato Arch. Exp. Med. 1954, 3:57-62.
33. Ko K.S., Peck K.R., Oh W.S., Lee N.Y., Lee J.H., Song J.H. New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst. J. Clin. Microbiol. 2005, 43:2516-2519.
34. Kuhn S., Zipfel P.F. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 1995, 2:225-229.
35. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 2:132-142.
36. Madico G., Welsch J.A., Lewis L.A., McNaughton A., Perlman D.H., Costello C.E., Ngampasutadol J., Vogel U., Granoff D.M., Ram S. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 2006, 1:501-510.
37. Manuelian T., Hellwage J., Meri S., Caprioli J., Noris M., Heinen S., Jozsi M., Neumann H.P., Remuzzi G., Zipfel P.F. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Invest. 2003, 8:1181-1190.
38. Marr N., Luu R.A., Fernandez R.C. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J. Infect. Dis. 2007, 4:585-588.
39. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005, 2:326-382.
40. Meri S., Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. U.S.A. 1990, 10:3982-3986.
41. Meri T., Hartmann A., Lenk D., Eck R., Wurzner R., Hellwage J., Meri S., Zipfel P.F. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 2002, 9:5185-5192.
42. Meri T., Jokiranta T.S., Hellwage J., Bialonski A., Zipfel P.F., Meri S. Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H. J. Infect. Dis. 2002, 12:1786-1793.
43. Ormsby R.J., Jokiranta T.S., Duthy T.G., Griggs K.M., Sadlon T.A., Giannakis E., Gordon D.L. Localization of the third heparin-binding site in the human complement regulator factor H1. Mol. Immunol. 2006, 10:1624-1632.
44. Pela I., Seracini D., Caprioli A., Castelletti F., Giammanco A. Hemolytic uremic syndrome in an infant following Bordetella pertussis infection. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 8:515-517.
45. Persson C.G. Plasma exudation in the airways: mechanisms and function. Eur. Respir. J. 1991, 10:1268-1274.
46. Pishko E.J., Betting D.J., Hutter C.S., Harvill E.T. Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect. Immun. 2003, 9:4936-4942.
47. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 1998, 5:743-752.
48. Rooijakkers S.H., Wu J., Ruyken M., van Domselaar R., Planken K.L., Tzekou A., Ricklin D., Lambris J.D., Janssen B.J., van Strijp J.A., Gros P. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 2009, 7:721-727.
49. Salacinski P.R., McLean C., Sykes J.E., Clement-Jones V.V., Lowry P.J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal. Biochem. 1981, 1:136-146.
50. Sharma A.K., Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 1996, 20:10996-11001.
51. Skerka C., Horstmann R.D., Zipfel P.F. Molecular cloning of a human serum protein structurally related to complement factor H. J. Biol. Chem. 1991, 18:12015-12020.
52. Smith A.M., Guzman C.A., Walker M.J. The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol. Rev. 2001, 3:309-333.
53. Stainer D.W., Scholte M.J. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 1970, 2:211-220.
54. Vandamme P., Heyndrickx M., Vancanneyt M., Hoste B., De Vos P., Falsen E., Kersters K., Hinz K.H. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int. J. Syst. Bacteriol. 1996, 4:849-858.
55. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 14:1058-1066.
56. Weyant R.S., Hollis D.G., Weaver R.E., Amin M.F., Steigerwalt A.G., O'Connor S.P., Whitney A.M., Daneshvar M.I., Moss C.W., Brenner D.J. Bordetella holmesii sp. nov., a new Gram-negative species associated with septicemia. J. Clin. Microbiol. 1995, 1:1-7.
57. Wood N., McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr. Respir. Rev. 2008, 3:201-211. (quiz 211-2).
58. Wu J., Wu Y.Q., Ricklin D., Janssen B.J., Lambris J.D., Gros P. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 2009, 7:728-733.
59. Zipfel P.F., Jokiranta T.S., Hellwage J., Koistinen V., Meri S. The factor H protein family. Immunopharmacology 1999, 1-3:53-60.
60. Zipfel P.F., Skerka C., Hellwage J., Jokiranta S.T., Meri S., Brade V., Kraiczy P., Noris M., Remuzzi G. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 2002, 30(Pt 6):971-978.